U.S. Markets close in 2 hrs 18 mins

Vivos Therapeutics, Inc. (VVOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.13-0.42 (-4.40%)
As of 1:37PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.55
Open10.11
Bid9.05 x 1100
Ask9.17 x 3100
Day's Range9.01 - 10.86
52 Week Range5.64 - 14.41
Volume295,317
Avg. Volume166,288
Market Cap161.297M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.00
  • GlobeNewswire

    Vivos Therapeutics to Participate at the Emerging Growth Conference

    Vivos management to present at 9:00 am EDT on April 14, 2021HIGHLANDS RANCH, Colo., April 12, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced that Kirk Huntsman, Chief Executive Officer, Brad Amman, Chief Financial Officer and Ed Loew, Investor Relations Officer, will be presenting at the Emerging Growth Conference at 9:00 am EDT on Wednesday, April 14, 2021. Investors interested in joining the Vivos presentation can register for a free spectator pass at the link below: https://goto.webcasts.com/starthere.jsp?ei=1451311&tp_key=5b36cea9ad&sti=vvos A replay of the presentation will be available for view following the presentation on Vivos’ website at: https://vivoslife.com/investor-relations/ About Vivos Therapeutics, Inc.Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have proven effective in over 15,000 patients treated worldwide by more than 1,200 trained dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.vivoslife.com. About the Emerging Growth Conference The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner. The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts. For more information and/or to register for the conference please visit: https://goto.webcasts.com/starthere.jsp?ei=1451311&tp_key=5b36cea9ad&sti=vvos Cautionary Note Regarding Forward-Looking StatementsThis press release, the presentation referred to herein, and the statements of the Company’s management made in connection therewith contain “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, particularly with respect to the public offering described herein. Words such as “may”, “should”, “expects”, “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon a number of assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond Vivos’ control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in Vivos’ filings with the Securities and Exchange Commission (“SEC”). Vivos’ filings can be obtained free of charge on the SEC's website at www.sec.gov. Except to the extent required by law, Vivos expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Vivos' expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Investor Relations Contact:Edward LoewInvestor Relations Officer(602) 903-0095ed@vivoslife.com Media Relations Contact:Caitlin Kasunich / Jenny RoblesKCSA Strategic Communications(212) 896-1241 / (917) 420-1444ckasunich@kcsa.com / jrobles@kcsa.com

  • CEO Presenting on the Emerging Growth Conference on April 14; Register now
    GlobeNewswire

    CEO Presenting on the Emerging Growth Conference on April 14; Register now

    Niche Companies in Therapeutics, Energy, Defense and more in AttendanceMIAMI, April 12, 2021 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies announces the Schedule of the 5th Emerging Growth Conference. EmergingGrowth.com is proud to present and welcome you to the 5th Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. The schedule for March 31st from 9:30 AM until 4:00 PM is as follows: (All times are Eastern Time Zone) We may see some schedule changes on Wednesday. To stay current on the schedule, please follow us on Twitter: https://twitter.com/EmergingGrowthC 9:00 – 9:45Vivos Therapeutics Inc. (NASDAQ: VVOS) Kirk Huntsman, CEO Brad Amman, CFO Edward Lowe, IRP 9:45 – 10:30Revive Therapeutics, (OTC Pink: RVVTF) Michael Frank, President & CEO Derrick Welsh, COO 10:30 - 11:15Lobe Sciences (OTC Pink: GTSIF) (CSE: LOBE) Phillip Young, CEO 11:15 – 12:00AMMO, Inc. (NASDAQ: POWW) Chris Larson, Founder 12:00 – 12:30Foothills Exploration, Inc. (OTC: FTXP) Chris Jarvis, Executive VP 12:30 - 1:15Xtreme Fighting Championships, Inc. (OTC Pink: DKMR) Steve Smith, CEO Myron Molotky, President 1:15 - 2:00Ur-Energy (NYSE American: URG) (TSX: URE) Jeffrey Klenda, Chairman & CEO 2:00 - 2:30International Consolidated Companies, Inc. (OTC Pink: INCC) Antonio Uccello, CEO 2:30 – 3:00PHI Group, Inc. (OTC Pink: PHIL) Henry Fahman, Chairman & CEO 3:00 - 3:30Enzolytics, Inc. (OTC Pink: ENZC) Charles Cotropia, CEO 3:30 - 4:00First Graphene Ltd. (OTC Pink: FGPHF) (ASX: FGR) Warwick Grigor, Chairman All interested in attending should visit the following link to register. You will then receive an email containing the link and time to sign into the conference. Register for the conference here. We may see some schedule changes on Wednesday. To stay current on the schedule, please follow us on Twitter: https://twitter.com/EmergingGrowthC These exciting virtual conferences are like attending an “in person” event, you can sign in and out as often as you like. About EmergingGrowth.comFounded in 2009, Emerging Growth.com quickly became a leading independent small cap media portal. Over the years, it has developed an extensive history of providing unparalleled content, in identifying emerging growth companies and markets that can be overlooked by the investment community. The next step in its evolution is the Emerging Growth Conference. About the Emerging Growth ConferenceThe Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in an effective and time efficient manner. The Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. The audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts. Thanks for participating and make sure you to follow us on Twitter and YouTube to be the first to hear updates on the Conference and when the Conferences are available for replay. All Conferences are first announced on Twitter – Follow us on Twitter All Conference replays emerge on our YouTube Channel – Subscribe to our YouTube Channel All sessions will be conducted through video webcasts and will take place in the Eastern time zone. Provided above is the current Emerging Growth Conference schedule for featured presentations. Each company’s presentations will be delivered by their executive management team. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com. If you believe your company, product or service is at the cusp of going mainstream, or you have an idea for an “Emerging Growth” company that might fit our model, contact us here. Thank you for your interest in our conference, and we look forward to your participation in future conferences. Contact: Emerging Growth Phone: 1-305-330-1985Email: Conference@EmergingGrowth.com

  • Motley Fool

    Investing in Sleep Apnea Companies

    In this episode of Industry Focus: Wildcard, join Motley Fool contributor Brian Feroldi and host Emily Flippen as they talk about three companies trying to treat sleep apnea: ResMed (NYSE: RMD), Inspire Medical (NYSE: INSP), and Vivos Therapeutics (NASDAQ: VVOS). To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Today is Wednesday, March 24th, and I am your host, Emily Flippen.